• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与肺功能差相关的因素:欧洲囊性纤维化流行病学注册研究(ERCF)数据的横断面分析

Factors associated with poor pulmonary function: cross-sectional analysis of data from the ERCF. European Epidemiologic Registry of Cystic Fibrosis.

作者信息

Navarro J, Rainisio M, Harms H K, Hodson M E, Koch C, Mastella G, Strandvik B, McKenzie S G

机构信息

Dept of Gastroenterology and Cystic Fibrosis, Robert Debré Hospital, AP/HP, Paris, France.

出版信息

Eur Respir J. 2001 Aug;18(2):298-305. doi: 10.1183/09031936.01.00068901.

DOI:10.1183/09031936.01.00068901
PMID:11529288
Abstract

The European Epidemiologic Registry of Cystic Fibrosis began collecting longitudinal data on European cystic fibrosis patients in 1994. A cross-sectional analysis was performed to identify the factors associated with low values of % predicted forced expiratory volume in one second (FEV1) upon patient enrollment. Data from 7,010 patients aged > or =6 yrs were included. Clinical conditions, microbiological isolates and medications reported at enrollment or within the following 180 days were analysed for age-specific associations. Factors associated with FEV1 that were lower by >10% of pred values were: lower weight for age percentiles, haemoptysis, pneumothorax, pulmonary symptoms at presentation, Pseudomonas aeruginosa, Burkholderia cepacia, oral corticosteroids, nonsteroid anti-inflammatory drugs, dornase alfa, oxygen and assisted ventilation and, in patients >12 yrs old only, use of airway clearance techniques, inhaled bronchodilators, oral nutritional supplements, pancreatic enzymes and insulin or oral hypoglycaemics. Slightly impaired lung function (5-10%) was associated with: diabetes (> or = 18-yrs-old), gastro-oesophageal reflux, allergic bronchopulmonary aspergillosis, asthma-like symptoms, portal hypertension, Aspergillus spp. and Candida spp. Sex, Haemophilus influenzae and Staphylococcus aureus were not associated with impaired pulmonary status. Regular exercise (especially in older patients) and nasal polyposis were associated with slightly better FEV1. The results confirm those of previous studies and suggest selective prescribing in sicker patients.

摘要

欧洲囊性纤维化流行病学登记处自1994年开始收集欧洲囊性纤维化患者的纵向数据。进行了一项横断面分析,以确定患者入组时与一秒用力呼气量(FEV1)预测值低相关的因素。纳入了7010名年龄≥6岁的患者的数据。分析了入组时或随后180天内报告的临床状况、微生物分离株和药物的年龄特异性关联。与FEV1低于预测值>10%相关的因素有:年龄别体重百分位数较低、咯血、气胸、就诊时的肺部症状、铜绿假单胞菌、洋葱伯克霍尔德菌、口服皮质类固醇、非甾体抗炎药、重组人脱氧核糖核酸酶、吸氧和辅助通气,仅在12岁以上患者中,还有气道廓清技术的使用、吸入性支气管扩张剂、口服营养补充剂、胰酶以及胰岛素或口服降糖药。肺功能轻度受损(5-10%)与以下因素相关:糖尿病(≥18岁)、胃食管反流、变应性支气管肺曲霉病、哮喘样症状、门静脉高压、曲霉属和念珠菌属。性别、流感嗜血杆菌和金黄色葡萄球菌与肺功能受损无关。规律运动(尤其是老年患者)和鼻息肉与FEV1稍好相关。结果证实了先前研究的结果,并提示对病情较重的患者进行选择性用药。

相似文献

1
Factors associated with poor pulmonary function: cross-sectional analysis of data from the ERCF. European Epidemiologic Registry of Cystic Fibrosis.与肺功能差相关的因素:欧洲囊性纤维化流行病学注册研究(ERCF)数据的横断面分析
Eur Respir J. 2001 Aug;18(2):298-305. doi: 10.1183/09031936.01.00068901.
2
The clinical presentations of pulmonary aspergillosis in children with cystic fibrosis - preliminary report.囊性纤维化患儿肺曲霉病的临床表现——初步报告
Dev Period Med. 2015 Jan-Mar;19(1):66-79.
3
Allergic bronchopulmonary aspergillosis in cystic fibrosis. A European epidemiological study. Epidemiologic Registry of Cystic Fibrosis.囊性纤维化中的变应性支气管肺曲霉病。一项欧洲流行病学研究。囊性纤维化流行病学登记处。
Eur Respir J. 2000 Sep;16(3):464-71. doi: 10.1034/j.1399-3003.2000.016003464.x.
4
[International registry on mucoviscidosis: comparison of the French data with the European data for 1995].[国际黏多糖贮积症登记处:1995年法国数据与欧洲数据的比较]
Arch Pediatr. 1998 Apr;5(4):384-8. doi: 10.1016/s0929-693x(98)80024-9.
5
Effect of allergic bronchopulmonary aspergillosis on FEV in children and adolescents with cystic fibrosis: a European Cystic Fibrosis Society Patient Registry analysis.变应性支气管肺曲霉病对囊性纤维化儿童和青少年第一秒用力呼气量的影响:一项欧洲囊性纤维化协会患者登记分析。
Arch Dis Child. 2017 Aug;102(8):742-747. doi: 10.1136/archdischild-2016-311132. Epub 2017 Mar 21.
6
Patterns of medical practice in cystic fibrosis: part II. Use of therapies. Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis.囊性纤维化的医疗实践模式:第二部分。治疗方法的使用。囊性纤维化流行病学研究的调查人员和协调员。
Pediatr Pulmonol. 1999 Oct;28(4):248-54. doi: 10.1002/(sici)1099-0496(199910)28:4<248::aid-ppul3>3.0.co;2-n.
7
Risk factors for lung disease progression in children with cystic fibrosis.囊性纤维化患儿肺部疾病进展的危险因素。
Eur Respir J. 2018 Jun 7;51(6). doi: 10.1183/13993003.02509-2017. Print 2018 Jun.
8
Infant care patterns at epidemiologic study of cystic fibrosis sites that achieve superior childhood lung function.囊性纤维化疾病研究点的婴儿护理模式,这些研究点儿童期肺功能表现优异。
Pediatrics. 2007 Mar;119(3):e531-7. doi: 10.1542/peds.2006-1414.
9
Monitoring clinical and microbiological evolution of a cystic fibrosis patient over 26 years: experience of a Brazilian CF Centre.26 年随访监测一例囊性纤维化患者的临床和微生物学演变:巴西囊性纤维化中心的经验。
BMC Pulm Med. 2017 Jul 14;17(1):100. doi: 10.1186/s12890-017-0442-2.
10
Relationship between nutritional status and lung function in cystic fibrosis: cross sectional and longitudinal analyses from the German CF quality assurance (CFQA) project.囊性纤维化患者营养状况与肺功能的关系:来自德国囊性纤维化质量保证(CFQA)项目的横断面和纵向分析
Thorax. 2002 Jul;57(7):596-601. doi: 10.1136/thorax.57.7.596.

引用本文的文献

1
Unveiling the molecular epidemiology of Pseudomonas aeruginosa in lung infections among cystic fibrosis patients in the Brazilian Amazon.揭示巴西亚马逊地区囊性纤维化患者肺部感染中铜绿假单胞菌的分子流行病学。
BMC Microbiol. 2025 Apr 9;25(1):203. doi: 10.1186/s12866-025-03920-w.
2
Effect of Candida albicans' supernatant on biofilm formation and virulence factors of Pseudomonas aeruginosa through las/rhl System.白色念珠菌上清液通过las/rhl系统对铜绿假单胞菌生物膜形成和毒力因子的影响
BMC Microbiol. 2025 Feb 1;25(1):60. doi: 10.1186/s12866-024-03604-x.
3
The interactions of Candida albicans with gut bacteria: a new strategy to prevent and treat invasive intestinal candidiasis.
白色念珠菌与肠道细菌的相互作用:预防和治疗侵袭性肠道念珠菌病的新策略。
Gut Pathog. 2023 Jun 27;15(1):30. doi: 10.1186/s13099-023-00559-8.
4
Supplemental Oxygen Alters the Airway Microbiome in Cystic Fibrosis.补充氧气会改变囊性纤维化患者的气道微生物组。
mSystems. 2022 Oct 26;7(5):e0036422. doi: 10.1128/msystems.00364-22. Epub 2022 Aug 24.
5
Exposure to bile and gastric juice can impact the aerodigestive microbiome in people with cystic fibrosis.暴露于胆汁和胃液会影响囊性纤维化患者的气液消化微生物组。
Sci Rep. 2022 Jun 30;12(1):11114. doi: 10.1038/s41598-022-15375-4.
6
Assessment of the microbial load of airway clearance devices used by a cohort of children with cystic fibrosis.对一组囊性纤维化患儿使用的气道清理装置的微生物负荷评估。
Infect Prev Pract. 2021 Jun 6;3(3):100153. doi: 10.1016/j.infpip.2021.100153. eCollection 2021 Sep.
7
The Impact of Highly Effective CFTR Modulators on Growth and Nutrition Status.高效 CFTR 调节剂对生长和营养状况的影响。
Nutrients. 2021 Aug 24;13(9):2907. doi: 10.3390/nu13092907.
8
New Insights in Microbial Species Predicting Lung Function Decline in CF: Lessons from the MucoFong Project.微生物物种预测囊性纤维化肺功能下降的新见解:来自黏液真菌项目的经验教训。
J Clin Med. 2021 Aug 21;10(16):3725. doi: 10.3390/jcm10163725.
9
Systems Biology and Bile Acid Signalling in Microbiome-Host Interactions in the Cystic Fibrosis Lung.系统生物学与囊性纤维化肺部微生物群-宿主相互作用中的胆汁酸信号传导
Antibiotics (Basel). 2021 Jun 24;10(7):766. doi: 10.3390/antibiotics10070766.
10
Luminal Gastrointestinal Manifestations of Cystic Fibrosis.囊性纤维化的胃肠道腔面表现。
Curr Gastroenterol Rep. 2021 Mar 23;23(3):4. doi: 10.1007/s11894-021-00806-5.